Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 5

first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  new psychoactive substances
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Has the COVID-19 pandemic changed substance use patterns, drug market and drug response in Poland?

100%
Malczewski A., Kidawa M., Dalmata M.
Journal of Geography, Politics and Society
|
2022
|
vol. 12
|
issue 1
42-58
EN
The aim of this paper is to examine the impact of COVID-19 on the prevalence of substance use. Moreover, the analysis will focus on the impact of the pandemic on the drug market and drug-related crime in Poland. The tested hypothesis assumes that the COVID-19 pandemic has increased the prevalence of substance use and the related problems, and that the availability of drugs decreased. The data presented and processed for the purposes of this publication come from the monitoring of drugs and drug addiction and from different studies from 2020 to 2022. The analyses presented in the article do not show an increase in the use of psychoactive substances during the pandemic; furthermore, it is possible to indicate a decrease in the consumption of alcoholic beverages in 2020. It seems that the COVID-19 pandemic did not have a large impact on the availability and use of new psychoactive substances (NPS). The analysis of the drug market during the pandemic COVID-19 did not show a fall in the availability of drugs at the national level.
2
Publication available in full text mode
Content available

Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis

100%
Engelgardt P., Krzyżanowski M., Piotrowski P., Borkowska-Sztachańska M., Wasilewska A.
International Journal of Occupational Medicine and Environmental Health
|
2022
|
vol. 35
|
issue 4
485-495
EN
ObjectivesThe study assessed the presence of new psychoactive substances (NPS) in comparison to “classic” drugs in the group of newly admitted patients with mental and behavioral disorders due to the use of psychoactive substances diagnosis (section F11–19 according to ICD-10).Material and MethodsData from anamnesis and the blood and urine samples were collected from 116 patients diagnosed with mental and behavioral disorders due to psychoactive substance use. All of them expressed written informed consent. Analytical confirmation was obtained by highperformance liquid chromatography coupled to tandem mass spectrometry (LC/MS/MS). Liquid-liquid extraction was used for sample preparation.ResultsIn the sample, 108 (93%) of 116 were positive for psychoactive substances (including 96 cases where >1 substance was found), 69% of individuals were tested positive for opioids and 67% for benzodiazepines. Eleven (9%) of 116 patient samples were positive for NPS. We detected 7 different substances. Six of them were synthetic cannabinoids: PB-22, MDMB-CHMICA, MMB-CHMICA, AB-CHMINACA, MMB-FUBINACA, THJ-2201 and one synthetic cathinone 3-CMC.ConclusionsThe prevalence and NPS profile (the predominance of synthetic cannabinoids) are similar in the group of people with addiction to psychoactive substances as in populations of people taking recreational drugs and the overdose patients admitted to the hospital.
3
Publication available in full text mode
Content available

Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities

100%
Engelgardt P., Krzyżanowski M., Piotrowski P., Borkowska-Sztachańska M., Wasilewska A., Kowalkowski T.
International Journal of Occupational Medicine and Environmental Health
|
2020
|
vol. 33
|
issue 2
125-136
EN
ObjectivesThis study analyzed the prevalence of new psychoactive substance (NPS) use in the analyzed group and compared demographic features and psychoactive substance profiles between the 2 subgroups (NPS users, non-NPS users). The secondary measure was used to determine the prevalence of psychiatric comorbidities in study group and to compare demographic features and psychoactive substance profiles between 2 subgroups (the F11–19 only diagnosed group and the F11–19 group with psychiatric comorbidities according to ICD-10).Material and MethodsA 12-month retrospective cross-sectional analysis of medical records compiled for adult psychiatric patients who had been admitted to the Regional Psychiatric Hospital in Olsztyn, Poland, in October 1, 2016 – September 30, 2017 was conducted. After analyzing the available medical records, 157 cases were included and analyzed. Data for the study were collected in a specially designed monitoring card from discharge reports, including data from psychiatric examinations, especially anamnesis. Results: The most commonly declared psychoactive substances were amphetamine (AMF) – 54% and cannabinoids – 46%. The prevalence of NPS use in the study group was 34%. Inpatients taking NPS, as compared with non-NPS users, were younger and more often admitted to hospital through the Emergency Department. It was also found that NPS users more often took AMF or cannabinoids, and less frequently benzodiazepines (BDZ) or opioids. However, the taking of AMF, cannabinoids and BDZ was also age-dependent.ConclusionsThe prevalence of psychiatric comorbidities in the study group was 9%. Inpatients with psychiatric comorbidities were older and took BDZ significantly more often than AMF. In addition, NPS use affects different groups, including a specific group as the analyzed sample, which shows a similar NPS use profile as different groups described in the literature.
4
Publication available in full text mode
Content available

New psychoactive substances. The phenomenon development and the institutional and legal mechanisms for its prevention

84%
Semków D.
Journal of Modern Science
|
2019
|
issue 1(40)
45-64
EN
The phenomenon observed in many countries for many years is an attempt to bypass the law by launching psychoactive substances on the market whose possession and sale is not regulated by the existing drug law. The number of chemically and biologically modified substances is dramatically increasing and the substances themselves are increasingly stronger and threatening people’s health and lives. Issues relating to the occurrence of New Psychoactive Substances (NPS) are the subject of increasingly in-depth analyses. In connection with the steadily increasing number of NPS and their substantial availability, there are more and more doubts about the effectiveness of the model adopted in earlier years in Europe and in individual countries, whose purpose is to subject new psychoactive substances to legal control. Based on the information presented in the article, one can assume that the reason for the development of new psychoactive substances to date was, on the one hand, the weakness of the legal regulations in force, both national and international, and on the other, specialized technical and chemical capabilities of manufacturers. Another thesis that can be put in the context of the studied subject is the statement that the phenomenon of new psychoactive substances has a high criminogenic susceptibility and is a decisively negative phenomenon, classified as the pathology of social life. In view of the above, the activities of prevention, detection and control of new psychoactive substances are important in the process of effective fight against NPS. The article does not constitute a comprehensive and complex overview of what NPS are. The aim of the study is a multifaceted analysis of the phenomenon of such substances, which will allow for a deeper understanding of the causes of such a wide scale of NPS, their diversity and ease of accessibility. Considering the above, the article attempts to stress the priority issues according to the article’s author and which are crucial in the process of universally understood NPS prevention – i.e. international cooperation, national legal regulations, and chemical analyses conducted in forensic laboratories.
5
Publication available in full text mode
Content available

Therapeutic Interventions for Addicts in Prisons

67%
Piasecka M., Podolak E.
Studia Paedagogica Ignatiana
|
2023
|
vol. 26
|
issue 2
103-122
EN
The phenomenon of drug addiction is prevalent among prisoners. The lack of therapeutic or adequate interventions for addicts can be a risk factor for recidivism. Therefore, it is important follow methods that have been documented as effective. The purpose of this article is to present the results of an analysis of foundational data on therapeutic programs conducted in prison wards and targeting drug addicts, including those addicted to new psychoactive substances. The results of the research focus on identifying individual elements of the programs resulting from their structure and the level of inclusion of interventions documented as effective in addiction therapy. The conclusions and recommendations from the desk research lead to recommendations for improving penitentiary practice.
PL
Zjawisko uzależnienia od substancji psychoaktywnych, w tym tzw. dopalaczy, występuje wśród osób pozbawionych wolności. Brak oddziaływań terapeutycznych lub nieadekwatne oddziaływania skierowane do osób z uzależnieniem mogą stanowić czynniki ryzyka recydywy penitencjarnej. Dlatego ważne jest, aby działania prowadzone w tym zakresie opierały się na metodach udokumentowanych jako skuteczne. Celem artykułu jest prezentacja wyników badań prowadzonych na podstawie analizy danych zastanych dotyczących programów terapeutycznych wdrażanych na oddziałach w jednostkach penitencjarnych i skierowanych do osób z uzależnieniem od substancji psychoaktywnych innych niż alkohol, w tym od nowych substancji psychoaktywnych. Wyniki badań koncentrują się na identyfikacji poszczególnych elementów programów wynikających z przyjętej ich struktury oraz poziomu uwzględnienia oddziaływań udokumentowanych jako skutecznie w terapii uzależnień. Wnioski i zalecenia wypływające z przeprowadzonych badań źródeł wtórnych pozwalają na wyprowadzenie rekomendacji dla doskonalenia praktyki penitencjarnej.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.